DONATE
English
English
Français Italiano Español
  • About
    • What is ARSACS?
    • Our Mission
    • What We Do
    • Our Team
      • Founders
      • Board of Directors
      • Researchers
  • Persons with ARSACS
    • International Patient Registry
    • Frequently Asked Questions
    • Patient Participation
      • Research Study
      • Preclinical and Clinical Trials
    • ARSACS Exercise Program at Home
    • Connect with ARSACS Community
  • Research
    • Research Grants
    • Current Research Projects
    • Past Projects
    • Research Project Reports
    • Research Tools
    • Partnerships
    • Publications
  • How You Can Help
  • Conferences & Events
    • 2026 International ARSACS Symposium
    • Past Conferences
  • News
  • Contact
  • About
    • What is ARSACS?
    • Our Mission
    • What We Do
    • Our Team
      • Founders
      • Board of Directors
      • Researchers
  • Persons with ARSACS
    • International Patient Registry
    • Frequently Asked Questions
    • Patient Participation
      • Research Study
      • Preclinical and Clinical Trials
    • ARSACS Exercise Program at Home
    • Connect with ARSACS Community
  • Research
    • Research Grants
    • Current Research Projects
    • Past Projects
    • Research Project Reports
    • Research Tools
    • Partnerships
    • Publications
  • How You Can Help
  • Conferences & Events
    • 2026 International ARSACS Symposium
    • Past Conferences
  • News
  • Contact
DONATE
English
English
Français Italiano Español

SacsR272C missense homozygous mice develop an ataxia phenotype

Mar 19, 2019 | News Archives

The research of Dr. Roxanne Larivière and her team supports that Sacs missense mutation largely leads to loss of Sacsin fucntion. SacsR272C missense homozygous mice develop an ataxia phenotype published in the Molecular Brain.
Together, We’re Advancing ARSACS Research — $1M Investment

Together, We’re Advancing ARSACS Research — $1M Investment

Sep 14, 2026 | Latest News

read more...

Investigating Ferroptosis as a Therapeutic Target in ARSACS – Dr. Currais

Sep 11, 2026 | Current Research

read more...

Identifying Genetic Modifiers That May Influence ARSACS Symptoms – Dr. Girard

Sep 11, 2026 | Current Research

read more...
« Older Entries
  • Follow
  • Follow
  • Follow

Connect with the ARSACS community online

Stay tuned on the latest news and development. Join the ARSACS community via the different social media Facebook, X and LinkedIn.



Location

1000 Sherbrooke O, bur. 2100, Montréal, QC H3A 3G4



Contact

1 (514) 370-3625
ataxia@arsacs.com

Contact Ataxia Charlevoix-Saguenay Foundation

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Copyright © 2026, Ataxia Charlevoix-Saguenay Foundation | Privacy Policy | 856980321RR0001